Overview

Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men

Status:
NOT_YET_RECRUITING
Trial end date:
2027-08-01
Target enrollment:
Participant gender:
Summary
A Phase 4, multi-center, open-label, single-arm 24-hour Ambulatory Blood Pressure Monitoring (ABPM) study of Testosterone Cypionate Injection in Hypogonadal Men to assess change in 24-hour ambulatory blood pressure from Baseline to End of Treatment
Phase:
PHASE4
Details
Lead Sponsor:
Azurity Pharmaceuticals
Collaborator:
CBCC Global Research
Treatments:
testosterone 17 beta-cypionate